10x Genomics Cash on Hand 2018-2025 | TXG
10x Genomics cash on hand from 2018 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
10x Genomics Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $393 |
| 2023 | $389 |
| 2022 | $433 |
| 2021 | $588 |
| 2020 | $680 |
| 2019 | $424 |
| 2018 | $65 |
| 2017 | |
|
10x Genomics Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-09-30 | $482 |
| 2025-06-30 | $447 |
| 2025-03-31 | $427 |
| 2024-12-31 | $393 |
| 2024-09-30 | $398 |
| 2024-06-30 | $380 |
| 2024-03-31 | $372 |
| 2023-12-31 | $389 |
| 2023-09-30 | $357 |
| 2023-06-30 | $393 |
| 2023-03-31 | $421 |
| 2022-12-31 | $433 |
| 2022-09-30 | $453 |
| 2022-06-30 | $500 |
| 2022-03-31 | $539 |
| 2021-12-31 | $588 |
| 2021-09-30 | $600 |
| 2021-06-30 | $640 |
| 2021-03-31 | $635 |
| 2020-12-31 | $680 |
| 2020-09-30 | $828 |
| 2020-06-30 | $398 |
| 2020-03-31 | $372 |
| 2019-12-31 | $424 |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | $65 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.249B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.780B | 46.01 |
| Tempus AI (TEM) | United States | $13.638B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.924B | 72.59 |
| Doximity (DOCS) | United States | $8.647B | 35.60 |
| IRhythm Technologies (IRTC) | United States | $5.747B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.975B | 65.77 |
| Hinge Health (HNGE) | United States | $3.939B | 0.00 |
| Privia Health (PRVA) | United States | $2.932B | 183.38 |
| Heartflow (HTFL) | United States | $2.344B | 0.00 |
| Omnicell (OMCL) | United States | $1.817B | 37.15 |
| Azenta (AZTA) | United States | $1.607B | 66.13 |
| Enovis (ENOV) | United States | $1.545B | 8.11 |
| Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Phreesia (PHR) | United States | $1.216B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.859B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.773B | 0.00 |
| Claritev (CTEV) | United States | $0.561B | 0.00 |
| Standard BioTools (LAB) | United States | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Talkspace (TALK) | United States | $0.510B | 102.67 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.414B | 0.00 |
| Carlsmed (CARL) | United States | $0.353B | 0.00 |
| TruBridge (TBRG) | United States | $0.346B | 15.88 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| CapsoVision (CV) | United States | $0.323B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.270B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.170B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.167B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.150B | 0.00 |
| CareCloud (CCLD) | United States | $0.132B | 7.23 |
| EUDA Health Holdings (EUDA) | Singapore | $0.101B | 0.00 |
| Pulmonx (LUNG) | United States | $0.083B | 0.00 |
| Outset Medical (OM) | United States | $0.080B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.077B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.070B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.038B | 0.00 |
| 111 (YI) | China | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.029B | 0.00 |
| HeartBeam (BEAT) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| PROFUSA (PFSA) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |